We are excited to announce that Cilcare will be participating in the ARO 2025 Annual Meeting in Orlando, Florida, from February 22-26, 2025. This major event brings together leaders in auditory research, and we invite you to visit us at Booth #1 to discover the latest developments in hearing therapeutics and discuss potential collaborations.
Our team, including Dr. Gaëlle Naert (COO & CSO) and Sébastien Diot (Program Leader), will be on hand to share insights into our cutting-edge research and services, along with our partners from CBSET, represented by Dr. Donald Hodges (Senior Scientist) and Dr. Ellie Khadir (Study Director).
This year, Cilcare and CBSET are proud to sponsor the Pharmaceutical Interventions for Hearing Loss (PIHL) Satellite Symposium on February 21, 2025, from 1:00 to 5:00 PM EST, taking place just before the main ARO conference.
Organized by the Defense Health Agency (DHA) Hearing Center of Excellence (HCE), the symposium will spotlight the latest advances in investigational medicines aimed at preventing and restoring hearing loss. It will offer a comprehensive overview of the inner ear medicine discovery pipeline, highlight key resources for the development of biologics and pharmaceuticals, and provide updates on the progress of promising therapeutic agents. A unique opportunity to gain valuable insights directly from leading experts in the field !
Dr. Gaëlle Naert will be presenting at the symposium, joined by an esteemed group of speakers, including:
- Tim Bölke, MD (Acousia Therapeutics)
- Jonas Dyhrfjeld-Johnsen, PhD (Acousia Therapeutics)
- Amanda Henton, PhD (Turner Scientific)
- Ralph Holme, PhD (Royal National Institute for the Deaf)
- Jonathon Kil, MD (Sound Pharmaceuticals)
- Gaëlle Naert, PhD (Cilcare)
We look forward to meeting you both at the symposium and at our booth !